Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

Related Articles by Review for PubMed (Select 17322915)

1.

Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.

Klein E, Kis LL, Klein G.

Oncogene. 2007 Feb 26;26(9):1297-305. Review.

PMID:
17322915
2.

Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.

Klein G, Klein E, Kashuba E.

Biochem Biophys Res Commun. 2010 May 21;396(1):67-73. doi: 10.1016/j.bbrc.2010.02.146. Review.

PMID:
20494113
3.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
4.

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

Kis LL, Takahara M, Nagy N, Klein G, Klein E.

Immunol Lett. 2006 Apr 15;104(1-2):83-8. Epub 2005 Dec 1. Review.

PMID:
16386314
5.

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

Young LS, Murray PG.

Oncogene. 2003 Aug 11;22(33):5108-21. Review.

PMID:
12910248
6.

Epstein-Barr virus-associated lymphomas.

Gandhi MK.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):77-89. Review.

PMID:
16441211
7.

B cells under influence: transformation of B cells by Epstein-Barr virus.

K├╝ppers R.

Nat Rev Immunol. 2003 Oct;3(10):801-12. Review.

PMID:
14523386
8.

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

Dolcetti R.

Autoimmun Rev. 2007 Dec;7(2):96-101. Epub 2007 Mar 26. Review.

PMID:
18035317
9.

Pathogenesis of Epstein-Barr virus (EBV)-carrying lymphomas.

Klein E, Kis LL, Takahara M.

Acta Microbiol Immunol Hung. 2006 Dec;53(4):441-57. Review.

PMID:
17278712
10.

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Pang MF, Lin KW, Peh SC.

Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Review.

PMID:
19082921
11.

The ecology and pathology of Epstein-Barr virus.

Schmidt CW, Misko IS.

Immunol Cell Biol. 1995 Dec;73(6):489-504. Review.

12.

Spectrum of Epstein-Barr virus-associated diseases.

Kutok JL, Wang F.

Annu Rev Pathol. 2006;1:375-404. Review.

PMID:
18039120
13.

The complexity of the Epstein-Barr virus infection in humans.

Klein E.

Pathol Oncol Res. 1998;4(1):3-7. Review.

14.

Reactivation of Epstein-Barr virus from latency.

Amon W, Farrell PJ.

Rev Med Virol. 2005 May-Jun;15(3):149-56. Review.

PMID:
15546128
15.

A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells.

Thorley-Lawson DA, Babcock GJ.

Life Sci. 1999;65(14):1433-53. Review.

PMID:
10530796
16.

Epstein-Barr virus: 40 years on.

Young LS, Rickinson AB.

Nat Rev Cancer. 2004 Oct;4(10):757-68. Review.

PMID:
15510157
17.

Epstein-Barr virus-associated lymphoproliferative disorders.

Rezk SA, Weiss LM.

Hum Pathol. 2007 Sep;38(9):1293-304. Review.

PMID:
17707260
18.

Epstein-Barr virus-recent advances.

Macsween KF, Crawford DH.

Lancet Infect Dis. 2003 Mar;3(3):131-40. Review.

PMID:
12614729
19.

Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.

Delecluse HJ, Feederle R, Behrends U, Mautner J.

Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Review.

PMID:
18938248
20.

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

Niller HH, Wolf H, Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Review.

PMID:
19429479
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk